| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Thursday’s Close |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $105.71 | $113.53B | N/A |
Teva Investors Get Headache Relief
https://www.wsj.com/articles/teva-investors-get-headache-relief-1537200489?mod=rss_Technology
Sep 17, 2018 - A new migraine drug is a big win amid the turnaround of generics business.
4
GW Pharmaceuticals Up on Encouraging Schizophrenia Data
http://www.zacks.com/stock/news/190320/gw-pharmaceuticals-up-on-encouraging-schizophrenia-data?cid=CS-ZC-FT-190320
Sep 16, 2015 - GW Pharmaceuticals plc (GWPH) announced encouraging top-line data from an exploratory phase IIa study on cannabidiol in patients suffering from schizophrenia who had previously failed to respond adequately to first-line anti-psychotic medications.
4
Earnings Growth Accelerates in Q1
http://www.zacks.com/commentary/111002/earnings-growth-accelerates-in-q1?cid=CS-ZC--111002
Apr 21, 2017 - Earnings Growth Accelerates in Q1
4
Stocks making the biggest moves premarket: MMM, UTX, VZ, LLY & more
https://www.cnbc.com/2018/07/24/stocks-making-the-biggest-moves-premarket-mmm-utx-vz-lly--more.html
Jul 24, 2018 - Names on the move ahead of the open.
4
Earnings Growth Returns, Will it Continue?
http://www.zacks.com/commentary/102303/earnings-growth-returns-will-it-continue?cid=CS-ZC--102303
Jan 27, 2017 - Earnings Growth Returns, Will it Continue?
3
Why Alder Biopharma Stock Is Crashing Today
https://www.fool.com/investing/2017/06/27/why-alder-biopharma-stock-is-crashing-today.aspx?source=iedfolrf0000001
Jun 27, 2017 - Disappointing phase 3 trial results are increasing concerns that its migraine drug might not be a commercial success.
2
Why Snyder's-Lance, Incyte, and Tenet Healthcare Slumped Today
https://www.fool.com/investing/2017/04/17/why-snyders-lance-incyte-and-tenet-healthcare-slum.aspx?source=iedfolrf0000001
Apr 17, 2017 - Despite a climbing market, these stocks fell. Find out why.
1
What Happened in the Stock Market Today
https://www.fool.com/investing/2017/04/17/what-happened-in-the-stock-market-today.aspx?source=iedfolrf0000001
Apr 18, 2017 - Drugmakers get denied, Chipotle continues gains, and earnings season gets under way. Investors have remained optimistic ahead of what could be a tumultuous week.
1
Big Pharma Diabetes Drugs Not So Sweet. What's in Store?
http://www.zacks.com/stock/news/262544/big-pharma-diabetes-drugs-not-so-sweet-whats-in-store?cid=CS-ZC-FT-262544
May 31, 2017 - Aales of diabetes drugs from most large pharma companies slipped in the first quarter.
1
The Key Reason Incyte Corporation Added $850 Million in Market Cap in August
https://www.fool.com/investing/2017/09/05/the-key-reason-incyte-corporation-added-850-millio.aspx?source=iedfolrf0000001
Sep 05, 2017 - An update on bariticinib's review timeline has Wall Street rightly excited.
1